| Product Code: ETC7660238 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Prophylactic Vaccines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Israel Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Israel Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Israel Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Israel Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Israel Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Israel Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Israel Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Israel |
4.2.2 Government initiatives promoting vaccination programs |
4.2.3 Growing prevalence of infectious diseases in Israel |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy among certain population groups |
4.3.2 Regulatory challenges in the approval process for new vaccines |
4.3.3 High costs associated with vaccine development and distribution |
5 Israel Prophylactic Vaccines Market Trends |
6 Israel Prophylactic Vaccines Market, By Types |
6.1 Israel Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Israel Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Israel Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Israel Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Israel Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Israel Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Israel Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Israel Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Israel Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Israel Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Israel Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Israel Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Israel Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Israel Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Israel Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Israel Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Israel Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Israel Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Israel Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Israel Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Israel Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Israel Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Israel Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Israel Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Israel Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Israel Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Israel Prophylactic Vaccines Market Export to Major Countries |
7.2 Israel Prophylactic Vaccines Market Imports from Major Countries |
8 Israel Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population groups |
8.2 Number of new vaccines introduced to the market |
8.3 Research and development investment in vaccine technologies |
9 Israel Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Israel Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Israel Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Israel Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Israel Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Israel Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Prophylactic Vaccines Market - Competitive Landscape |
10.1 Israel Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Israel Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here